The Synthetic Biology Innovation Network

SynBioBeta is the premier innovation network for innovators, investors, engineers and thinkers who share a passion for using synthetic biology to build a better, more sustainable universe.
The Global
Synthetic Biology Summit

SVN West
San Francisco, California
Tuesday-Thursday, Oct. 1-3, 2019

REGISTER NOW!
The Global
Synthetic Biology Summit

SVN West
San Francisco, California
Tuesday-Thursday, Oct. 1-3, 2019

Stay updated on the latest news in synthetic biology with

You can have the Green New Deal and your hamburger, too

Some critics of the Green New Deal claim that the far-left wants to take away your hamburger -- but Silicon Valley startups may already have the win-win solution. Could cellular agriculture be the Green New Deal’s saving grace -- at least when it comes to meat?

SynBioBeta’s First Green New Deal Town Hall: Sweeping Visions, Growing Consensus

In the same week that Representative Alexandria Ocasio-Cortez (D-N.Y.) is reportedly gathering co-sponsors for a resolution that would formally introduce the Green New Deal into the U.S. House of Representatives, SynBioBeta hosted its first online town hall on the Green New Deal.

Checkerspot raises $13M Series A to produce biotech-enabled performance materials

Algal oils create raw materials for sustainable products with superior properties

The best kept secret in drug discovery has a Twist

Emily Leproust, Twist’s CEO, suggests that her CSO’s best-kept secret for drug discovery will soon be let out of the bag -- it’s already on its way out.

previous arrow
next arrow
Slider

Editors' picks

NanoRacks

Why automation in space is a critical investment

Stem cells are a critical tool in the scientist’s toolbox. Stem cell therapies have been developed for a range of applications, from growing new heart muscle cells and replacing those damaged during a heart attack, to...

Press releases

EdiGENE Raises $15 million in Series B Funding

Tokyo Japan and Cambridge, Mass. –April 10th, 2019–EdiGENE, an emerging biotechnology company developing new CRISPR based therapies for treatment of genetic disorders, announced todaythat it has raised 1.6 Billion-yen...

News by topic